Tag: preclinical
-
Carb-X Funds Drug-Resistant Bacterial Vaccine
A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria.
-
FDA Okays Celiac Disease Engineered Microbe Trial
A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease.
-
Nanotube Fibers Configured for Heart Repair
Medical and engineering researchers developed fibers made with nanoscale carbon tubes that in lab animals conducted electrical signals and repaired heart damage.
-
Engineered Bacteria Hydrogels Designed for Gut Repair
Biomedical engineers genetically altered bacteria that when added to gel materials can be applied like a spray or ointment to help heal intestinal surfaces.
-
MD Anderson, Drug Maker Partner on Lung, GI Cancers
MD Anderson Cancer Center and drug maker Boehringer Ingelheim agreed to jointly develop new treatments for lung and gastrointestinal cancers.
-
Spray-On Hydrogel Reduces Heart Surgery Scar Tissue
A biocompatible polymer gel, sprayed on the hearts of lab animals, reduces the severity of scar tissue that can build up after cardiac surgery.
-
FDA Investigating Data Manipulation in Gene Therapy Approval
The Food and Drug Administration is investigating manipulation of preclinical tests submitted for its approval of a gene therapy to treat a rare disease.
-
Company Forms to Treat Vaginal Microbial Disorders
A new enterprise has launched to develop live microbial treatments for urinary tract infections and other diseases originating in vaginal bacterial communities.
-
Nanotech Vaccine Aids Melanoma Immunotherapy
A vaccine made with nanoscale peptide particles can prevent the occurrence of melanoma in lab mice, and treat the condition when combined with other drugs.
-
Protein-Eluding Scaffolds Help Grow New Blood Vessels
A polymer frame infused with proteins that stimulate immune cells encourages growth of new blood vessels in lab mice with peripheral artery disease.